AdaptHealth (AHCO)
(Real Time Quote from BATS)
$9.49 USD
+0.41 (4.52%)
Updated Aug 8, 2024 11:18 AM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
AdaptHealth Corp. (AHCO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.95 | $16.00 | $7.00 | 31.61% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for AdaptHealth Corp. comes to $11.95. The forecasts range from a low of $7.00 to a high of $16.00. The average price target represents an increase of 31.61% from the last closing price of $9.08.
Analyst Price Targets (10)
Broker Rating
AdaptHealth Corp. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 10% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/22/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
5/15/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
3/17/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
3/4/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
2/27/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
1/29/2024 | UBS | Kevin Caliendo | Not Available | Strong Buy |
1/8/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 10 |
Average Target Price | $11.95 |
LT Growth Rate | 17.70% |
Industry | Medical - Products |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | 0.23 |